CIK 0001018735 · Accelerated filer
NYMOX PHARMACEUTICAL CORP
Sign in to watch- Ticker
- NYMXF
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Entity type
- other
- Phone
- 1-800-936-9669
- Business address
- 9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 95 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| No insider trades stored. | ||||||